Wang Yichen, Huang Yuting, Al Jawish Mhd Manar, Bakheet Nader G, Acosta Andres, Ordog Tamas, Clift Kristin, Chase Katherine, Kumbhari Vivek, Badurdeen Dilhana S
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
J Gen Intern Med. 2025 Apr;40(5):1097-1106. doi: 10.1007/s11606-024-09033-w. Epub 2024 Sep 20.
The global rise in overweight, obesity, and related diseases is undeniable; however, the pathogenesis of obesity and obesity-associated diseases is heterogeneous, with varied complications and a discordant response to treatment. Intriguingly, men have a shorter lifespan than women, despite being half as likely to be obese. This paradox suggests a potential gender disparity in the impact of obesity on mortality, with men potentially being more vulnerable to obesity-associated health risks.
This retrospective study utilized Global Burden of Diseases data from 204 countries/territories to bridge the knowledge gap in understanding gender disparities in obesity-related mortality. Outcomes were obesity-associated mortality, years of life lost, years lived with disability, and disability-adjusted life years (DALYs).
In 2019, the global overweight/obesity-related disease burden reached 160.2 million DALYs, with 5.02 million associated deaths. From 1990 to 2019, the age-standardized death rates increased in males (from 58.19 to 66.55 per 100,000 person-years, APC = 0.36%, 95% CI: 0.30 to 0.42%, P < 0.001), while females experienced a decrease in age-standardized death rates (from 59.31 to 58.14 per 100,000 person-years, APC = -0.22%, 95% CI: -0.29% to -0.14%, P < 0.001). Age-standardized DALYs increased more in males (1632.5 to 2070.34 per 100,000 years, APC = 0.74%, 95% CI: 0.70% to 0.78%, P < .001) compared to females (1618.26 to 1789.67 per 100,000 years, APC = 0.24%, 95% CI: 0.19% to 0.29%, P < 0.001). Disparities were more pronounced in countries with a higher socioeconomic status and predominantly affected younger populations.
Overweight/obesity-related morbidity and mortality are higher among male sex. Identifying differences in pathogenesis, complications and treatment response is crucial to develop targeted interventions and equitable public health policies to combat this global burden.
超重、肥胖及相关疾病在全球范围内呈上升趋势,这是不可否认的;然而,肥胖及肥胖相关疾病的发病机制是异质性的,并发症多样,对治疗的反应也不一致。有趣的是,男性的寿命比女性短,尽管男性肥胖的可能性只有女性的一半。这种矛盾表明,肥胖对死亡率的影响可能存在性别差异,男性可能更容易受到肥胖相关健康风险的影响。
这项回顾性研究利用了来自204个国家/地区的全球疾病负担数据,以填补在理解肥胖相关死亡率的性别差异方面的知识空白。研究结果包括肥胖相关死亡率、寿命损失年数、带病生存年数和伤残调整生命年(DALYs)。
2019年,全球超重/肥胖相关疾病负担达到1.602亿伤残调整生命年,相关死亡人数为502万。1990年至2019年,男性的年龄标准化死亡率有所上升(从每10万人年58.19例增至66.55例,年平均变化百分比[APC]=0.36%,95%置信区间[CI]:0.30%至0.42%,P<0.001),而女性的年龄标准化死亡率则有所下降(从每10万人年59.31例降至58.14例,APC=-0.22%,95%CI:-0.29%至-0.14%,P<0.001)。男性年龄标准化伤残调整生命年的增加幅度大于女性(从每10万年1632.5例增至2070.34例,APC=0.74%,95%CI:0.70%至0.78%,P<0.001)(女性从每10万年1618.26例增至1789.67例,APC=0.24%,95%CI:0.19%至0.29%,P<0.001)。在社会经济地位较高的国家,差异更为明显,且主要影响年轻人群体。
男性中超重/肥胖相关的发病率和死亡率更高。识别发病机制、并发症和治疗反应方面的差异,对于制定有针对性的干预措施和公平的公共卫生政策以应对这一全球负担至关重要。